Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 58.49 - -
Change - -45.55% -68.19% 94.7% -47.8% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 58.49 58.49 58.49
Change - -45.55% -68.19% 94.7% -47.8% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 48.7x 45x 36.6x
EV / Revenue - 0x 0x 0x 48.7x 45x 36.6x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -9x -9.14x -
EV / FCF - -0x - -0x -9.14x -16.2x -15x
FCF Yield - -9.52% - -4.08% -10.9% -6.15% -6.67%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.7310 0.7310 0.7310
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 3/1/23 5/15/24 5/13/25 5/13/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 71.19M
79.49x5.36x22.91x2.61% 322B
23.9x3.21x11.27x1.68% 70.24B
14.24x7.01x10.74x - 11.65B
16.58x2.1x7.12x2.73% 8.42B
21.27x6.74x17.95x-.--% 5.02B
42.98x2.69x30.74x0.66% 4.52B
36.43x6.87x19.65x - 4.25B
-234.4x - - -.--% 2.72B
Average 0.06x 4.86x 17.20x 1.28% 47.63B
Weighted average by Cap. 63.88x 4.99x 20.34x 2.38%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. AB Stock
  4. Valuation AB Science